The U.S. Department of Justice (DOJ) has recently taken a renewed interest in management services organizations (MSOs), including physician-syndicated MSOs in which physician-owners.
US Drug Enforcement Administration DEA released letter to registrants in support of Congress removal of requirement healthcare providers possess DATA-Waiver, X-Waiver, to prescribe buprenorphine for opioid use disorder OUD. Buprenorphine is lifesaving medication.
The Eliminating Kickbacks in Recovery Act is a criminal statute prohibiting paying or receiving anything of value in exchange for the referral of patients to recovery homes covered by a health care benefit program. In 2021, DOJ expanded the scope of its EKRA enforcement actions.
DEA Supports Elimination of X-Waiver Requirement for Prescribing of Buprenorphine | McDermott Will & Emery jdsupra.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jdsupra.com Daily Mail and Mail on Sunday newspapers.